A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer

被引：1
|
作者：
Soliman, Hatem H. [1 ]
Minton, Susan E. [1 ]
Ismail-Khan, Roohi [1 ]
Han, Hyo S. [1 ]
Vahanian, Nicholas N. [2 ]
Link, Charles J. [2 ]
Kennedy, Gene [2 ]
Streicher, Howard [3 ]
Sullivan, Daniel [1 ]
Antonia, Scott J. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Temple, TX USA
[2] NewLink Genet Inc, Ames, IA USA
[3] Natl Canc Inst, Bethesda, MD USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P2-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-15-04
引用
收藏
页数：2
相关论文
共 50 条
  • [21] An early phase 2 study with XELODA™ (capecitabine) in patients with metastatic breast cancer
    Saeki, T
    Takashima, S
    Terashima, M
    Tabei, T
    Enomoto, K
    Tominaga, T
    Kimura, T
    Miura, S
    Koyama, H
    Konishi, Y
    Oka, T
    Naito, Y
    Sonoo, H
    Toge, T
    Dohi, K
    Nomizu, T
    Taguchi, T
    ANNALS OF ONCOLOGY, 1998, 9 : 155 - 155
  • [22] A phase 2 study of low dose metronomic eribulin in metastatic breast cancer
    Chalasani, P.
    Liu, A. J.
    Khanjian, J. A.
    Peha, M.
    Buening, B. J.
    Gadi, V. K.
    Specht, J. M.
    Salazar, L.
    Linden, H. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Bilusic, Marijo
    McMahon, Sheri
    Madan, Ravi A.
    Karzai, Fatima
    Tsai, Yo-Ting
    Donahue, Renee N.
    Palena, Claudia
    Jochems, Caroline
    Marte, Jennifer L.
    Floudas, Charalampos
    Strauss, Julius
    Redman, Jason
    Sater, Houssein Abdul
    Rabizadeh, Shahrooz
    Soon-Shiong, Patrick
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [24] A Phase I Study Accessing Immunotherapy Combination of Balstilimab and Ivermectin in Patients with Metastatic Triple Negative Breast Cancer
    Yuan, Yuan
    Shiao, Stephen
    Tighiouart, Mourad
    Mita, Monica
    Bitar, Jin-Sun
    McAndrew, Philomena
    Dorothy, Park
    El-Masry, Maryliza
    Frankel, Paul
    Lee, Peter
    CANCER RESEARCH, 2024, 84 (09)
  • [25] A phase 1b study of PVX-410 vaccine in combination with pembrolizumab in metastatic triple negative breast cancer (mTNBC)
    Isakoff, Steven J.
    Tung, Nadine M.
    Yin, Jun
    Tayob, Nabihah
    Parker, Joanne
    Rosenberg, Julie
    Bardia, Aditya
    Spring, Laura
    Park, Hannah
    Collins, Maya
    Barry, William T.
    Severgnini, Mariano
    Peterkin, Doris
    Tolaney, Sara M.
    CANCER RESEARCH, 2022, 82 (04)
  • [26] A phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC)
    Bilusic, M.
    Madan, R. A.
    Karzai, F. H.
    McMahon, S.
    Donahue, R. N.
    Strauss, J.
    Gatti-Mays, M. E.
    Redman, J.
    Cordes, L. M.
    Palena, C.
    Gabitzsch, E. S.
    Jones, F. R.
    Balint, J. P.
    Soon-Shiong, P.
    Rabizadeh, S.
    Policard, M.
    Schlom, J.
    Gulley, J. L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
    R. Paridaens
    O. Rixe
    M. C. Pinel
    H. Wildiers
    G. Zorza
    P. Ferré
    H. Roche
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 503 - 511
  • [28] A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
    Paridaens, R.
    Rixe, O.
    Pinel, M. C.
    Wildiers, H.
    Zorza, G.
    Ferre, P.
    Roche, H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 503 - 511
  • [29] A phase II study of oral MKC-1 for metastatic breast cancer (MBC)
    Schneider, B. P.
    Karwal, M.
    Laufman, L.
    Sylvester, L.
    Taylor, M. A.
    Sidor, C.
    Hannah, A.
    Arnott, J.
    Miller, K. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer
    Fenn, Kathleen
    Maurer, Matthew
    Lee, Shing M.
    Crew, Katherine D.
    Trivedi, Meghna S.
    Accordino, Melissa K.
    Hershman, Dawn L.
    Kalinsky, Kevin
    CLINICAL BREAST CANCER, 2020, 20 (01) : 80 - 86
12345